Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Samaan

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Journal of Crohn'S & Colitis|March 12, 2020
Authors' Reply to: Type C Mucosa in Pouch Surveillance: Make-do and Mend Rather Than Start From Scratch?Mark A Samaan, Peter M Irving
Expert Opinion on Biological Therapy|May 18, 2016
The impact of updated NICE guidelines on biologic treatment of ulcerative colitis: reflections on past practices, the changing present and implications for the futureMark A Samaan, Peter M Irving
Digestive Diseases and Sciences|November 19, 2021
5-ASAs in Crohn's Disease: Time to Stop the Salicylate?Sailish Honap, Esha Sharma, Mark A Samaan
Alimentary Pharmacology & Therapeutics|March 4, 2022
Editorial: protecting hypoxia-inducible factor-1α and gut integrity with GB004-a promising therapeutic approach for ulcerative colitis?Sailish Honap, Robin J Dart, Mark A Samaan
Therapeutic Advances in Gastroenterology|February 8, 2019
Golimumab in the treatment of ulcerative colitisGeorgina Cunningham, Mark A Samaan, Peter M Irving
BMJ Case Reports|December 6, 2012
Going with the flowJames Edmund Sarkodieh, Mark A Samaan, Arman Parsai
European Journal of Gastroenterology & Hepatology|September 19, 2023
JAK inhibitors for the treatment of inflammatory bowel disease: results of an international survey of perceptions, attitudes, and clinical practiceSailish Honap, Peter M Irving, Mark A Samaan
Journal of Crohn'S & Colitis|August 12, 2022
Ustekinumab-Induced Inflammatory Demyelinating Polyneuropathy in a Patient with Ulcerative ColitisSailish Honap, Peter M Irving, Mark A Samaan
Alimentary Pharmacology & Therapeutics|July 31, 2019
Letter: immune checkpoint inhibitor-induced colitis-shouldn't we be checking more often?Mark A Samaan, Nick Powell, Peter M Irving
Digestive Diseases and Sciences|August 25, 2020
Vedolizumab Dose Escalation: In for a Penny, in for a Pound?Robin J Dart, Peter M Irving, Mark A Samaan
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Journal of Crohn'S & Colitis|March 12, 2020
Authors' Reply to: Type C Mucosa in Pouch Surveillance: Make-do and Mend Rather Than Start From Scratch?Mark A Samaan, Peter M Irving
Expert Opinion on Biological Therapy|May 18, 2016
The impact of updated NICE guidelines on biologic treatment of ulcerative colitis: reflections on past practices, the changing present and implications for the futureMark A Samaan, Peter M Irving
Digestive Diseases and Sciences|November 19, 2021
5-ASAs in Crohn's Disease: Time to Stop the Salicylate?Sailish Honap, Esha Sharma, Mark A Samaan
Alimentary Pharmacology & Therapeutics|March 4, 2022
Editorial: protecting hypoxia-inducible factor-1α and gut integrity with GB004-a promising therapeutic approach for ulcerative colitis?Sailish Honap, Robin J Dart, Mark A Samaan
Therapeutic Advances in Gastroenterology|February 8, 2019
Golimumab in the treatment of ulcerative colitisGeorgina Cunningham, Mark A Samaan, Peter M Irving
BMJ Case Reports|December 6, 2012
Going with the flowJames Edmund Sarkodieh, Mark A Samaan, Arman Parsai
European Journal of Gastroenterology & Hepatology|September 19, 2023
JAK inhibitors for the treatment of inflammatory bowel disease: results of an international survey of perceptions, attitudes, and clinical practiceSailish Honap, Peter M Irving, Mark A Samaan
Journal of Crohn'S & Colitis|August 12, 2022
Ustekinumab-Induced Inflammatory Demyelinating Polyneuropathy in a Patient with Ulcerative ColitisSailish Honap, Peter M Irving, Mark A Samaan
Alimentary Pharmacology & Therapeutics|July 31, 2019
Letter: immune checkpoint inhibitor-induced colitis-shouldn't we be checking more often?Mark A Samaan, Nick Powell, Peter M Irving
Digestive Diseases and Sciences|August 25, 2020
Vedolizumab Dose Escalation: In for a Penny, in for a Pound?Robin J Dart, Peter M Irving, Mark A Samaan
Pageof 7